Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 859.55
(2.64%)
INR 859.55
(2.64%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 34.41 Billion INR | 0.84% |
| 2023 | 34.13 Billion INR | -8.23% |
| 2022 | 37.19 Billion INR | 14.93% |
| 2021 | 32.36 Billion INR | 16.03% |
| 2020 | 27.89 Billion INR | 3.76% |
| 2019 | 26.88 Billion INR | 12.69% |
| 2018 | 23.85 Billion INR | 32.24% |
| 2017 | 18.03 Billion INR | 34.9% |
| 2016 | 13.37 Billion INR | -5.67% |
| 2015 | 14.17 Billion INR | 3.66% |
| 2014 | 13.67 Billion INR | 12.68% |
| 2013 | 12.13 Billion INR | 11.29% |
| 2012 | 10.9 Billion INR | 34.31% |
| 2011 | 8.11 Billion INR | 8.2% |
| 2010 | 7.5 Billion INR | 24.82% |
| 2009 | 6.01 Billion INR | 30.89% |
| 2008 | 4.59 Billion INR | 23.57% |
| 2007 | 3.71 Billion INR | 58.98% |
| 2006 | 2.33 Billion INR | 10.91% |
| 2005 | 2.1 Billion INR | 24.0% |
| 2004 | 1.7 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 34.41 Billion INR | 0.84% |
| 2024 Q1 | - INR | -100.0% |
| 2024 Q4 | 34.41 Billion INR | 0.0% |
| 2024 Q3 | - INR | -100.0% |
| 2024 Q2 | 33.03 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 34.13 Billion INR | -8.23% |
| 2023 Q4 | 34.13 Billion INR | 0.0% |
| 2023 Q2 | 34.04 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 37.19 Billion INR | 0.0% |
| 2022 FY | 37.19 Billion INR | 14.93% |
| 2022 Q2 | 35.18 Billion INR | 0.0% |
| 2021 Q2 | 28.18 Billion INR | 0.0% |
| 2021 Q4 | 32.36 Billion INR | 0.0% |
| 2021 FY | 32.36 Billion INR | 16.03% |
| 2020 Q4 | 27.89 Billion INR | 0.0% |
| 2020 FY | 27.89 Billion INR | 3.76% |
| 2020 Q2 | 25.73 Billion INR | 0.0% |
| 2019 Q2 | 26.51 Billion INR | 0.0% |
| 2019 FY | 26.88 Billion INR | 12.69% |
| 2019 Q4 | 26.88 Billion INR | 0.0% |
| 2018 Q2 | 20.1 Billion INR | 0.0% |
| 2018 Q4 | 23.85 Billion INR | 0.0% |
| 2018 FY | 23.85 Billion INR | 32.24% |
| 2017 Q2 | 15.5 Billion INR | 0.0% |
| 2017 FY | 18.03 Billion INR | 34.9% |
| 2017 Q4 | 18.03 Billion INR | 0.0% |
| 2016 Q4 | 13.37 Billion INR | 0.0% |
| 2016 FY | 13.37 Billion INR | -5.67% |
| 2016 Q2 | 14.52 Billion INR | 0.0% |
| 2015 Q2 | 15.03 Billion INR | 0.0% |
| 2015 Q4 | 14.17 Billion INR | 0.0% |
| 2015 FY | 14.17 Billion INR | 3.66% |
| 2014 Q4 | 13.67 Billion INR | 0.0% |
| 2014 Q2 | 13.68 Billion INR | 0.0% |
| 2014 FY | 13.67 Billion INR | 12.68% |
| 2013 FY | 12.13 Billion INR | 11.29% |
| 2013 Q2 | 11.16 Billion INR | 0.0% |
| 2013 Q4 | 12.13 Billion INR | 0.0% |
| 2012 Q4 | 10.9 Billion INR | 0.0% |
| 2012 FY | 10.9 Billion INR | 34.31% |
| 2011 FY | 8.11 Billion INR | 8.2% |
| 2010 FY | 7.5 Billion INR | 24.82% |
| 2009 FY | 6.01 Billion INR | 30.89% |
| 2008 FY | 4.59 Billion INR | 23.57% |
| 2007 FY | 3.71 Billion INR | 58.98% |
| 2006 FY | 2.33 Billion INR | 10.91% |
| 2005 FY | 2.1 Billion INR | 24.0% |
| 2004 FY | 1.7 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -109.42% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 64.908% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -416.344% |
| Granules India Limited | 13 Billion INR | -164.651% |
| Indoco Remedies Limited | 3.53 Billion INR | -874.877% |
| Achyut Healthcare Limited | 568 Thousand INR | -6059583.099% |
| Ajanta Pharma Limited | 8.28 Billion INR | -315.508% |
| Alkem Laboratories Limited | 26.61 Billion INR | -29.337% |
| Alpa Laboratories Limited | 136.65 Million INR | -25087.153% |
| Brooks Laboratories Limited | 96.1 Million INR | -35712.836% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -1410.387% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -2289.574% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -2805.849% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 45.841% |
| Eris Lifesciences Limited | 1.89 Billion INR | -1720.803% |
| FDC Limited | 3.88 Billion INR | -785.061% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | -36.961% |
| Gufic Biosciences Limited | 2 Billion INR | -1616.812% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -32812.591% |
| Ipca Laboratories Limited | 24.71 Billion INR | -39.274% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -22850.59% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -35034.335% |
| Lasa Supergenerics Limited | 190.43 Million INR | -17973.978% |
| Laurus Labs Limited | 18.45 Billion INR | -86.511% |
| Lupin Limited | 49.53 Billion INR | 30.521% |
| Mankind Pharma Limited | 15.53 Billion INR | -121.563% |
| Medicamen Biotech Limited | 593.75 Million INR | -5696.865% |
| Medico Remedies Limited | 163.37 Million INR | -20967.87% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -391.349% |
| Piramal Pharma Limited | 21.75 Billion INR | -58.184% |
| RPG Life Sciences Limited | 1.01 Billion INR | -3307.822% |
| Sigachi Industries Limited | 707.2 Million INR | -4766.892% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 65.122% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -1388.739% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -16226.637% |
| Unichem Laboratories Limited | 7.04 Billion INR | -388.437% |
| Wanbury Limited | 360.23 Million INR | -9454.676% |
| Windlas Biotech Limited | 621.89 Million INR | -5434.58% |
| ZIM Laboratories Limited | 812.62 Million INR | -4135.512% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | -8.1% |
| Hester Biosciences Limited | 755.81 Million INR | -4453.922% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -3054.523% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -11807.752% |
| Bal Pharma Limited | 878.11 Million INR | -3819.651% |
| Strides Pharma Science Limited | 11.26 Billion INR | -205.61% |
| Venus Remedies Limited | 1.21 Billion INR | -2728.416% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -435.404% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -385.355% |
| Shilpa Medicare Limited | 3.44 Billion INR | -897.86% |
| Aarti Drugs Limited | 4.85 Billion INR | -608.37% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -710.164% |
| Suven Life Sciences Limited | 7.08 Million INR | -485700.988% |
| Ind-Swift Limited | 640.91 Million INR | -5270.291% |
| Valiant Laboratories Limited | 100.15 Million INR | -34266.076% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -584.942% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -856.881% |
| Themis Medicare Limited | 705.74 Million INR | -4776.988% |
| Hikal Limited | 3.03 Billion INR | -1033.248% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -51.027% |
| Sequent Scientific Limited | 3.46 Billion INR | -894.102% |
| Novartis India Limited | 448.6 Million INR | -7572.537% |
| Wockhardt Limited | 6.4 Billion INR | -437.797% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -166.897% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -134892.352% |
| Neuland Laboratories Limited | 3.5 Billion INR | -882.216% |
| Morepen Laboratories Limited | 2.48 Billion INR | -1284.546% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -86206.419% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -2683.812% |